RxDoctor Payments Data

Garrett Green, MD

Radiation Oncology · Reno, NVNPI 1699034868

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 71.1% of it on its own, with 26 other manufacturers making up the rest. 2025 is the largest year on record at $33,234, more than ten times the $519 reported in 2019. Among radiation oncology clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,175in general payments, 2019–2025

Across 83 payments — averaging $447.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$26K
  • Sirtex Medical Inc$7K
  • GT Medical Technologies, Inc$1K
  • BD$500
  • Novocure Inc.$350
  • Medtronic$239
  • plus $2K from 21 others
$25,210in research payments, 2019–2025

Across 14 payments — averaging $1800.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novocure Inc.$25K

What the payments were for

  • Consulting fees$5,37514%
  • Speaking & faculty fees$18,97351%
  • Travel & lodging$6,96319%
  • Food & beverage$5,82316%
  • Education$420%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,175 in reported general payments places this provider in the 95th percentile of 47 radiation oncology providers in Nevada.

See all radiation oncology providers in Nevada

Medicare billing

Part B allowed, 2024
$221,987
Medicare patients
273
Services billed
2,420

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone16$198

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →